Skip to main content
. 2024 Jul 8;41(8):3419–3425. doi: 10.1007/s12325-024-02924-8

Fig. 1.

Fig. 1

Kaplan–Meier survival curves for all-cause mortality, by low (< 600 mg) and high (≥ 600 mg) levodopa equivalent daily dose in the member population with at least 2 years of follow-up: a entire cohort; b age at baseline < 75 years; c age at baseline ≥ 75 years; shading 95% confidence interval